The Philadelphia Eagles have moved quarterback Jalen Hurts to injured reserve following a diagnosis of a superficial blood clot. This development means Hurts will miss at least four games.
In a statement released Thursday, the team explained that Hurts had been undergoing treatment for nearly a week and even traveled to and from London during this period. Despite his condition, he played in London against the Jacksonville Jaguars and participated fully in practice the day before being sidelined for the upcoming game.
A visit to the training room on October 8th revealed issues following a cleating incident during the Rams game on October 4th. This initiated treatment for his calf, alongside his full practice sessions on Wednesday and Thursday. He continued to receive treatment and practice fully on Friday.
The medical staff, moving cautiously, conducted an ultrasound after the team landed in London. It revealed a superficial blood clot. Doctors in London, along with the Eagles’ medical staff, decided that Hurts could play safely, recommending another ultrasound within 72 hours of the game and his return to Philadelphia.
Despite unrestricted participation in the Sunday’s game, a follow-up ultrasound on Wednesday night showed movement within the clot. Consequently, Hurts is ruled out for Sunday’s match against the Panthers while the team evaluates further treatment. His health remains the primary concern.
Hurts’ absence includes games against NFC East competitors. He can return in Week 11 against the Steelers, barring any complications during the Week 10 bye.
Blood clots can severely impact health, potentially leading to a pulmonary embolism, stroke, or heart attack. They can cause tissue damage or be fatal without immediate intervention.
Tanner McKee, a seasoned backup quarterback, is prepared to start in Hurts’ place against the Panthers. McKee has two career starts with a 1-1 record.
The Eagles are already facing struggles this season, compounded by the absence of key players like DeVonta Smith and Saquon Barkley.
